Simbrinza Opthalmic – Canada Pharmacy

Description

SIMBRINZA® (brinzolamide/brimonidine tartrate ophthalmic suspension) 1%/0.2% combines two proven medications into a single treatment. The first (brinzolamide) decreases the production of the clear fluid inside your eye. The second (brimonidine) also decreases fluid production while increasing fluid outflow. Together, they can reduce high pressure in the eye.1 Take SIMBRINZA® Suspension as your doctor prescribes: the recommended dose is one drop in the affected eye(s) 3 times a day. If you are already using another type of eyedrop they should be taken at least 5 minutes apart.1

Directions

The recommended dose is one drop of SIMBRINZA® Suspension in the affected eye(s) three times daily. Shake well before use. SIMBRINZA® Suspension may be used concomitantly with other topical ophthalmic drug products to lower intraocular pressure. If more than one topical ophthalmic drug is being used, the drugs should be administered at least five (5) minutes apart.

Ingredients

brinzolamide/brimonidine tartrate ophthalmic suspension

Side Effects

The most commonly reported side effects include blurred vision, eye irritation, bad taste, dry mouth, and eye allergy.1 SIMBRINZA® Suspension is contraindicated in patients who are hypersensitive to any component of this product and neonates and infants under the age of 2 years.